Ewan K. Cobran, Ph.D.
@ewan_cobran
Pharmacoepidemiologist and Prostate Cancer Scientist | Faculty at @MayoClinic | Views are mine.
ID: 1344301727122657281
30-12-2020 15:19:07
118 Tweet
159 Followers
247 Following
Thank you Mayo Clinic , Mayo Clinic Comprehensive Cancer Center and @MayoEquity for your support for this #workworthdoing ! Thank you Prof FTO 🇳🇬🇺🇸 your the visionary COE leadership, compassion and #compass to maintain our #North.
Thanks to awesome mentors Prof FTO 🇳🇬🇺🇸!
Cancer survivorship care is multifaceted and complex. Learn more about #ModelsOfCare and related NCI Office of Cancer Survivorship events, funding opportunities, and resources on this OCS Special Focus Area page: cancercontrol.cancer.gov/ocs/special-fo…. #CancerSurvivors #SurvOnc #NationalCancerSurvivorsMonth
Wow, just an awesome week at the @NCICRCHD for the Career Professional Development Award Recipients Workshop. Truly, enjoyed Dr. Kimryn Rathmell presentation discussing the National Cancer Plan.
Inspiring to hear my Howard and AC3 sister Dr. Adanda A.M. Llanos at Columbia University University talk about her 3 R01s and the role of Networking and Collaboration in Innovation. Howard University and AC3 PROUD
Dr. Jennifer Erves, Dr. Juan Vasquez, and I all received @NCATS supplement award in the same cohort and we also all received NCI K Awards. Our R01s will be next! Mayo Clinic Comprehensive Cancer Center, Vanderbilt University, and Yale University.
Announcing Dr. Camille Ragin from Fox Chase Cancer Center as our new Section Editor for Disparities Research! Dr. Ragin studies the molecular epidemiology of cancer in the African diaspora and socio-cultural factors influencing cancer disparities among African-origin populations.
Extremely proud our Mayo Clinic Comprehensive Cancer Center Office of COE’s efforts in addressing the burden of cancer in minoritized & marginalized communities. Let me introduce you to our signature Evidence-Based Intervention Programs that comprehensively addresses cancer across the care continuum…
Heterogeneity of the Treatment Effect with PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: A Living Interactive Systematic Review and Meta-analysis out on European Urology sciencedirect.com/science/articl… This study aimed to evaluate the efficacy of PARP inhibitors